Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 696 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MQX8 | ISIN: US45784P1012 | Ticker-Symbol: GOV
Tradegate
27.03.25
19:48 Uhr
244,20 Euro
+5,20
+2,18 %
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
INSULET CORPORATION Chart 1 Jahr
5-Tage-Chart
INSULET CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
237,10240,6009:50
237,10240,6009:50

Aktuelle News zur INSULET Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiInsulet-Direktor Frederick Wayne verkauft Aktien im Wert von 501.875 US-Dollar2
24.03.Insulet Gains 62.9% in a Year: What's Driving the Stock?2
22.03.Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today3
20.03.Insulet Type 1 diabetes study shows gains in 3 months after starting first automated insulin pump9
20.03.Insulet's RADIANT Trial Results Highlight Significant Glycemic Benefits From Omnipod 5 Transition367WASHINGTON (dpa-AFX) - The RADIANT trial conducted by Insulet Corp. (PODD) highlighted significant glycemic improvements with the use of the Omnipod 5 Automated Insulin Delivery System. These...
► Artikel lesen
19.03.Insulet says data shows significant glycemic improvement with Omnipod 52
18.03.Insulet's corporate family rating upgraded by Moody's Ratings2
18.03.Insulet prices $450 million in senior notes due 20332
INSULET Aktie jetzt für 0€ handeln
18.03.Insulet announces pricing of senior notes due 20333
18.03.Insulet preist Anleihen im Wert von 450 Millionen US-Dollar mit Fälligkeit 20335
18.03.Insulet Corp. erhält Bonitätsverbesserung von S&P aufgrund starker Leistung und erwarteter Entschuldung1
18.03.Insulet Corp. gets credit rating upgrade by S&P on strong performance and expected deleveraging4
18.03.Insulet expands Omnipod 5 to more countries, prices $450M offering4
18.03.Insulet Announces $450 Mln Offering Of Senior Unsecured Notes Due 2033161WASHINGTON (dpa-AFX) - Insulet Corp. (PODD), Tuesday announced the decision to offer $450 million aggregate principal amount of senior unsecured notes due 2033 in a private placement.The company...
► Artikel lesen
18.03.Insulet plans $450 million senior notes offering3
18.03.Insulet announces proposed financing transactions3
18.03.Insulet Corporation: From Injections to Innovation - Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod 5 in Adults and Children with Type 1 Diabetes219Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the Company will present results...
► Artikel lesen
18.03.Insulet Corporation: Insulet Expands Omnipod 5 to Four More International Markets207The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Insulet Corporation (NASDAQ: PODD) (Insulet or the...
► Artikel lesen
17.03.Insulet Co. (NASDAQ:PODD) Sees Large Increase in Short Interest2
17.03.INSULET CORP - 8-K, Current Report3
Seite:  Weiter >>
104 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1